Diarrhea and Acute Renal Injury Culminating in Metformin-Induced Lactic Acidosis
- 1 Department of Medicine, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait
- 2 Department of Otolarygology, Ministry of Health, Kuwait City, Kuwait
Abstract
Background: Metformin (M) is an effective first-line hypoglycemic agent in obese type 2 diabetes mellitus due to its low cost and safety profile. The Case: A 66-year-man presented with shock due to lactic acidosis induced by M-supersaturation subsequent to acute renal failure following infective diarrhea. The drug has been used, by this patient, for >10 years without complication. Physical examination, laboratory tests, radiological investigations and blood cultures did not show evidence of new cardiac, hepatic and septic insult. Despite discontinuation of M and 2-days of aggressive hydration, bicarbonate infusions and pressors; toxic levels of the drug persisted and shock-state culminated in severe and oliguric renal failure with serum urea and creatinine up to 50 mmol/L and 1270 umol/L, respectively. Hence, continuous venovenous hemodiafiltration (CVVHDF) was used, for 16-hours, to remove the drug, correct his acidosis and support his severe renal complications. Hours after the procedure; drug level, lactic acidosis and its associated shock improved followed by gradual renal recovery. The patient was discharged after 6 days and serum creatinine reached his base line (180 umol/L) 2 weeks later. The drug was not recommended for his future use. Conclusion: M-induced lactic acidosis, should be considered in assessment of shock in M-treated patients and management of unstable patients indicates early-use of CVVHDF.
- UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of Intensive Blood-Glucose Control with Metformin on Complications in Overweight Patients with Type 2 Diabetes (UKPDS 34). Lancet, 352, 854-865. https://doi.org/10.1016/S0140-6736(98)07037-8
- DeFronzo, R.A. and Goodman, A.M. (1995) Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus. The Multicenter Metformin Study Group. The New England Journal of Medicine, 333, 541-549. https://doi.org/10.1056/NEJM199508313330902
- American Diabetes Association (2020) Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020. Diabetes Care, 43, S98-S110. https://doi.org/10.2337/dc20-S009
- DeFronzo, R., Fleming, G.A., Chen, K. and Bicsak, T.A. (2016) Metformin-Associated Lactic Acidosis: Current Perspectives on Causes and Risk. Metabolism, 65, 20-29. https://doi.org/10.1016/j.metabol.2015.10.014
- Salpeter, S., Greyber, E., Pasternak, G. and Salpeter, E. (2002) Risk of Fatal and Nonfatal Lactic Acidosis with Metformin Use in Type 2 Diabetes Mellitus. Cochrane Database of Systematic Reviews, 2, CD002967. https://doi.org/10.1002/14651858.CD002967
- Renda, F., Mura, P., Finco, G., Ferrazin, F., Pani, L. and Landoni, G. (2013) Metformin-Associated Lactic Acidosis Requiring Hospitalization. A National 10-Year Survey and a Systematic Literature Review. European Review for Medical and Pharmacological Sciences, 17, 45-49.
- Juneja, D., Nasa, P. and Jain, R. (2022) Metformin Toxicity: A Meta-Summary of Case Reports. World Journal of Diabetes, 13, 654-664. https://doi.org/10.4239/wjd.v13.i8.654
- Inzucchi, S.E., Lipska, K.J., Mayo, H., Bailey, C.J. and McGuire, D.K. (2014) Metformin in Patients with Type 2 Diabetes and Kidney Disease: A Systematic Review. JAMA, 312, 2668-2675. https://doi.org/10.1001/jama.2014.15298
- Duong, J.K., Kumar, S.S., Kirkpatrick, C.M., Greenup, L.C., Arora, M., et al. (2013) Population Pharmacokinetics of Metformin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus: Simulation of Doses According to Renal Function. Clinical Pharmacokinetics, 52, 373-384. https://doi.org/10.1007/s40262-013-0046-9
- Gong, L., Goswami, S., Giacomini, K.M., Altman, R.B. and Klein, T.E. (2012) Metformin Pathways: Pharmacokinetics and Pharmacodynamics. Pharmacogenet Genomics, 22, 820-827. https://doi.org/10.1097/FPC.0b013e3283559b22
- Calello, D.P., Liu, K.D., Wiegand, T.J., Roberts, D.M., et al. (2015) Extracorporeal Treatments in Poisoning Workgroup. Extracorporeal Treatment for Metformin Poisoning: Systematic Review and Recommendations from the Extracorporeal Treatments in Poisoning Workgroup. Critical Care Medicine, 43, 1716-1730. https://doi.org/10.1097/CCM.0000000000001002